drugset / Trial / NCT05072704

Opioid Free Anesthesia in Total Hip Arthroplasty

NCT05072704

Phase 3 Completed 80 enrolled CMC Ambroise Paré
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Total hip arthroplasty (THA) is one of the most common orthopedic surgical procedure and is associated with severe pain in the immediate postoperative period, thus limiting early recovery. Postoperative pain management in THA requires multimodal analgesia, combining drugs and injection of a local anesthetic (LA). But, the best anesthesia strategy to provide optimal postoperative analgesia in THA remains controversial. Opioid free anesthesia could limit the episodes of hyperalgesia as well as tolerance and addiction to opioids. The hypothesis of this study is that an opioid free anesthesia using dexmedetomidine could improve analgesia after THA. The main objective of this monocenter, prospective, randomized, triple-blind, controlled trial is to assess the interest of opioid free anesthesia using dexmedetomidine on morphine consumption after THA.

Timeline

Start
2022-02-03
Primary completion
2023-02-02
Completion
2023-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Comparator Sufentanil Other / unclassified 10 ug Intravenous

Indications

No indication recorded.